FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Dingli

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Anatomy

Hematopoietic Stem Cells

Physiology

Haematopoiesis

Living Beings

Co-author Network

Publications

TOP 3
Taxiarchis V Kourelis; Shaji Kumar; Robert Kyle; Martha Lacy; Nelson Leung; Yi Lin; John A Lust; Vincent S Rajkumar; Stephen Russell; Thomas Witzig; Steven R Zeldenrust; Clive Zent; Francis Buadi; David Dingli; Morie Gertz; Suzanne R Hayman; Prashant Kapoor; Angela Dispenzieri
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Joseph R Mikhael; S Vincent Rajkumar; Craig B Reeder; Vivek Roy; Stephen J Russell; Taimur Sher; Keith Stewart; Thomas E Witzig; Steven R Zeldenrust; Stephen M Ansell; P Leif Bergsagel; Francis K Buadi; Asher Chanan-Khan; Robert J Dalton; David Dingli; Angela Dispenzieri; Matthew T Drake; Rafael Fonseca; Morie A Gertz; Suzanne R Hayman; Prashant Kapoor; Shaji Kumar; Robert A Kyle; Nelson Leung; Yi Lin; John A Lust; Martha Q Lacy
Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013.
W I Gonsalves; Suzanne R Hayman; William J Hogan; Francis Buadi; David Dingli; Angela Dispenzieri; Morie A Gertz; Martha Q Lacy; Shaji Kumar
Second auto-SCT for treatment of relapsed multiple myeloma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Dingli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Taxiarchis V Kourelis; Shaji Kumar; Robert Kyle; Martha Lacy; Nelson Leung; Yi Lin; John A Lust; Vincent S Rajkumar; Stephen Russell; Thomas Witzig; Steven R Zeldenrust; Clive Zent; Francis Buadi; David Dingli; Morie Gertz; Suzanne R Hayman; Prashant Kapoor; Angela Dispenzieri
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.
American journal of hematology 2013;88(5):375-8.
2013: Joseph R Mikhael; S Vincent Rajkumar; Craig B Reeder; Vivek Roy; Stephen J Russell; Taimur Sher; Keith Stewart; Thomas E Witzig; Steven R Zeldenrust; Stephen M Ansell; P Leif Bergsagel; Francis K Buadi; Asher Chanan-Khan; Robert J Dalton; David Dingli; Angela Dispenzieri; Matthew T Drake; Rafael Fonseca; Morie A Gertz; Suzanne R Hayman; Prashant Kapoor; Shaji Kumar; Robert A Kyle; Nelson Leung; Yi Lin; John A Lust; Martha Q Lacy
Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013.
Mayo Clinic proceedings. Mayo Clinic 2013;88(4):360-76.
2013: W I Gonsalves; Suzanne R Hayman; William J Hogan; Francis Buadi; David Dingli; Angela Dispenzieri; Morie A Gertz; Martha Q Lacy; Shaji Kumar
Second auto-SCT for treatment of relapsed multiple myeloma.
Bone marrow transplantation 2013;48(4):568-73.
2013: Morie A Gertz; Francis Buadi; David Dingli; Angela Dispenzieri; William J Hogan; Shaji Kumar; Martha Q Lacy; Nelson Leung; Suzanne R Hayman
Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis.
Bone marrow transplantation 2013;48(4):557-61.
2013: Arne Traulsen; Tom Lenaerts; Jorge Pacheco; David Dingli
On the dynamics of neutral mutations in a mathematical model for a homogeneous stem cell population.
Journal of the Royal Society, Interface / the Royal Society 2013;10(79):20120810.
2013: Ivana N M Micallef; Luis F Porrata; Shirshendu Sinha; Jeffrey L Winters; Robert Wolf; Martha Q Lacy; Mark R Litzow; Stephen M Ansell; Francis Buadi; David Dingli; Angela Dispenzieri; Dennis A Gastineau; Morie A Gertz; Suzanne R Hayman; William J Hogan; David J Inwards; Patrick B Johnston; Shaji Kumar
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(1):87-93.
2012: Stefan Cordes; David Dingli; Angela Dispenzieri; Suzanne R Hayman; William J Hogan; Shaji K Kumar; Martha Q Lacy; Francis K Buadi; Morie A Gertz
Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis.
Cancer 2012;118(24):6105-9.
2012: Alan R Penheiter; Stephen J Russell; Claire E Bender; David Dingli; Stephanie K Carlson
Monitoring the initial delivery of an oncolytic measles virus encoding the human sodium iodide symporter to solid tumors using contrast-enhanced computed tomography.
The journal of gene medicine 2012;14(9-10):590-7.
2012: Jonathan S Bleeker; Francis Buadi; David Dingli; Angela Dispenzieri; Morie A Gertz; Suzanne R Hayman; William Hogan; Shaji Kumar; Dirk R Larson; Patricia A Pellikka; S Vincent Rajkumar; Martha Q Lacy
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation.
European journal of haematology 2012;89(3):228-35.
2012: Anita D'Souza; Dennis A Gastineau; Morie Gertz; Suzanne R Hayman; William Hogan; David J Inwards; Patrick Johnston; Shaji Kumar; Robert Kyle; Martha Lacy; Mark R Litzow; Ivana N M Micallef; Luis F Porrata; Steven R Zeldenrust; Stephen M Ansell; Francis Buadi; David Dingli; Angela Dispenzieri
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience.
Blood 2012;120(1):56-62.
2012: Rahma Warsame; Thomas E Witzig; Steven R Zeldenrust; Francis Buadi; David Dingli; Morie A Gertz; Philip R Greipp; Suzanne R Hayman; Shaji K Kumar; Robert A Kyle; Martha Q Lacy; Nelson Leung; John A Lust; Joseph Mikhael; S Vincent Rajkumar; Stephen J Russell; Angela Dispenzieri
Trends and outcomes of modern staging of solitary plasmacytoma of bone.
American journal of hematology 2012;87(7):647-51.
2012: Angela Dispenzieri; Rafael Fonseca; Morie A Gertz; Robert Hall; Suzanne R Hayman; Shaji K Kumar; P Lief Bergsagel; Francis Buadi; David Dingli; Betsy LaPlant; Kristina Laumann; John A Lust; Joseph R Mikhael; S Vincent Rajkumar; Craig Reeder; Vivek Roy; Stephen J Russell; A Keith Stewart; Thomas E Witzig; Steven R Zeldenrust; Martha Q Lacy
Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis.
Blood 2012;119(23):5397-404.
2012: Shaji K Kumar; Martha Q Lacy; Kristina M Laumann; John A Lust; Joseph R Mikhael; S Vincent Rajkumar; Craig B Reeder; Vivek Roy; Stephen J Russell; A Keith Stewart; Steven R Zeldenrust; Jacob Allred; Leif P Bergsagel; Francis K Buadi; David Dingli; Rafael Fonseca; Morie A Gertz; Philip R Greipp; Suzanne R Hayman; Angela Dispenzieri
Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial.
Blood 2012;119(21):4860-7.
2012: S Sinha; Martha Q Lacy; Ivana N M Micallef; S Vincent Rajkumar; Francis Buadi; David Dingli; Angela Dispenzieri; D A Gastineau; Morie A Gertz; Suzanne R Hayman; William J Hogan; Shaji Kumar
Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies.
Leukemia 2012;26(5):1119-22.
2012: D M Rommelfanger; Richard G Vile; Zeljko Bajzer; J Dev; C P Offord; David Dingli
Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling.
Gene therapy 2012;19(5):543-9.
2012: S Sinha; Martha Lacy; J Mikhael; S Vincent Rajkumar; Francis Buadi; K Detweiler-Short; David Dingli; Angela Dispenzieri; Morie A Gertz; Suzanne R Hayman; Shaji Kumar
Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy.
Leukemia 2012;26(4):839-41.
2012: Shaji Kumar; Robert A Kyle; Martha Q Lacy; Kristina Laumann; Nelson Leung; John A Lust; S Vincent Rajkumar; Stephen J Russell; Steven R Zeldenrust; Francis K Buadi; Colin Colby; David Dingli; Angela Dispenzieri; Philip R Greipp; Suzanne R Hayman; Morie A Gertz
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(9):989-95.
2012: Shaji K Kumar; Martha Q Lacy; Nelson Leung; S Vincent Rajkumar; Shirshendu Sinha; Francis K Buadi; David Dingli; Angela Dispenzieri; Francesca Gay; Suzanne R Hayman; William Hogan; Morie A Gertz
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma.
Cancer 2012;118(6):1585-92.
2012: Shaji Kumar; Robert A Kyle; Martha Q Lacy; John A Lust; Stephen J Russell; Steven R Zeldenrust; Leif Bergsagel; Francis K Buadi; David Dingli; Angela Dispenzieri; Rafael Fonseca; Morie A Gertz; Alexandra Greenberg; Suzanne R Hayman; Rhett P Ketterling; Ryan A Knudson; S Vincent Rajkumar
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics.
Blood 2012;119(9):2100-5.
2012: Alan R Penheiter; stephen russell; David Dingli; Mark J Federspiel; guy griesmann; Stephanie K Carlson
Pinhole micro-SPECT/CT for noninvasive monitoring and quantitation of oncolytic virus dispersion and percent infection in solid tumors.
Gene therapy 2012;19(3):279-87.
2012: Sumit Madan; S Vincent Rajkumar; Francis K Buadi; David Dingli; Angela Dispenzieri; Martha Grogan; Suzanne R Hayman; William J Hogan; Shaji K Kumar; Martha Q Lacy; Nelson Leung; Morie A Gertz
High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement.
Blood 2012;119(5):1117-22.
2011: Benjamin Werner; David Dingli; Tom Lenaerts; Jorge M Pacheco; Arne Traulsen
Dynamics of mutant cells in hierarchical organized tissues.
PLoS computational biology 2011;7(12):e1002290.
2011: Anita D'Souza; Morie A Gertz; Philip R Greipp; Suzanne R Hayman; Shaji Kumar; Robert A Kyle; Martha Q Lacy; John A Lust; Michelle Mauermann; S Vincent Rajkumar; Stephen J Russell; Thomas E Witzig; Steven R Zeldenrust; Francis Buadi; David Dingli; Angela Dispenzieri
The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome.
Blood 2011;118(17):4663-5.
2011: Martha Q Lacy; Kristina Laumann; John A Lust; Sumithra J Mandrekar; S Vincent Rajkumar; Craig Reeder; Vivek Roy; Stephen J Russell; Kristen Detweiler Short; A Keith Stewart; Steven R Zeldenrust; Jacob B Allred; P Leif Bergsagel; Francis Buadi; David Dingli; Angela Dispenzieri; Rafael Fonseca; Morie A Gertz; Philip R Greipp; Suzanne R Hayman; Shaji Kumar; Joseph R Mikhael
Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease.
Blood 2011;118(11):2970-5.
2011: Sumit Madan; S Vincent Rajkumar; Steven R Zeldenrust; Martha Q Lacy; John Lust; Francis Buadi; Kristen Detweiler-Short; David Dingli; Angela Dispenzieri; Morie A Gertz; Philip R Greipp; Suzanne R Hayman; Shaji Kumar
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma.
Blood 2011;118(7):1763-5.
2011: Shaji K Kumar; Martha Q Lacy; Kristina Laumann; John A Lust; Joseph R Mikhael; S Vincent Rajkumar; Craig B Reeder; Stephen J Russell; Keith Stewart; Thomas E Witzig; Steven R Zeldenrust; Jacob Allred; P Leif Bergsagel; Francis K Buadi; David Dingli; Rafael Fonseca; Morie A Gertz; Philip R Greipp; Suzanne R Hayman; Angela Dispenzieri
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial.
American journal of hematology 2011;86(8):640-5.
2011: P Kapoor; Shaji Kumar; Robert A Kyle; Martha Q Lacy; K M Laumann; Sumithra J Mandrekar; S Vincent Rajkumar; David Dingli; Angela Dispenzieri; Morie A Gertz; Philip R Greipp; Thomas E Witzig
Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma.
Leukemia 2011;25(7):1195-7.
2011: Morie A Gertz; Francis Buadi; David Dingli; Angela Dispenzieri; William J Hogan; Shaji Kumar; Martha Q Lacy; Nelson Leung; Suzanne R Hayman
Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.
Bone marrow transplantation 2011;46(7):970-5.
2011: S Sinha; Jeffrey L Winters; Martha Lacy; Mark R Litzow; Ivana N M Micallef; Luis F Porrata; Stephen M Ansell; Francis Buadi; David Dingli; Angela Dispenzieri; Dennis A Gastineau; Morie A Gertz; C Greiner; Suzanne R Hayman; W Hogan; David J Inwards; P Johnston; Shaji Kumar
Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.
Bone marrow transplantation 2011;46(7):943-9.
2011: Sandra M S Herrmann; Morie A Gertz; Mark D Stegall; Angela Dispenzieri; Fernando C Cosio; Shaji Kumar; Martha Q Lacy; Patrick G Dean; Mikel Prieto; Steven R Zeldenrust; Francis K Buadi; Stephen J Russell; Scott L Nyberg; Suzanne R Hayman; David Dingli; Fernando C Fervenza; Nelson Leung
Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2011;26(6):2032-6.
2011: Tom Lenaerts; Fausto Castagnetti; Arne Traulsen; Jorge M Pacheco; Gianantonio Rosti; David Dingli
Explaining the in vitro and in vivo differences in leukemia therapy.
Cell cycle (Georgetown, Tex.) 2011;10(10):1540-4.
2011: P Kapoor; S Vincent Rajkumar; Angela Dispenzieri; Morie A Gertz; Martha Q Lacy; David Dingli; J R Mikhael; V Roy; Robert A Kyle; Philip R Greipp; Shaji Kumar; Sumithra J Mandrekar
Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis.
Leukemia 2011;25(4):689-96.
2011: Harris V K Naina; R K Pruthi; David J Inwards; David Dingli; Mark R Litzow; Stephen M Ansell; H J William; Angela Dispenzieri; Francis Buadi; Michelle A Elliott; Dennis A Gastineau; Morie A Gertz; Suzanne R Hayman; Patrick B Johnston; Martha Q Lacy; Ivana N M Micallef; Luis F Porrata; Shaji Kumar
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization.
Bone marrow transplantation 2011;46(2):291-3.
2011: David Dingli; Jorge M Pacheco
Stochastic dynamics and the evolution of mutations in stem cells.
BMC biology 2011;9():41.
2011: Shaji K Kumar; Morie A Gertz; Martha Q Lacy; David Dingli; Suzanne R Hayman; Francis K Buadi; Kristen Short-Detweiler; Steven R Zeldenrust; Nelson Leung; Philip R Greipp; John A Lust; Stephen J Russell; Robert A Kyle; S Vincent Rajkumar; Angela Dispenzieri
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score.
Mayo Clinic proceedings. Mayo Clinic 2011;86(1):12-8.
2011: Sergio Siragusa; William Morice; Morie A Gertz; Robert A Kyle; Philip R Greipp; John A Lust; Thomas E Witzig; Martha Q Lacy; Steven R Zeldenrust; S Vincent Rajkumar; Stephen J Russell; Suzanne R Hayman; Francis Buadi; Shaji K Kumar; David Dingli; Angela Dispenzieri
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
Annals of hematology 2011;90(1):101-6.
2010: Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Suzanne R Hayman; Shaji K Kumar; David Dingli; Stephen M Ansell; Dennis A Gastineau; David J Inwards; Patrick B Johnston; Mark R Litzow; Ivana N M Micallef; Luis F Porrata; Nelson Leung; William J Hogan; Francis K Buadi
Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report.
Leukemia & lymphoma 2010;51(12):2181-7.
2010: Martha Q Lacy; Suzanne R Hayman; Morie A Gertz; K D Short; Angela Dispenzieri; Shaji Kumar; Philip R Greipp; John A Lust; stephen russell; David Dingli; Steven R Zeldenrust; Rafael Fonseca; P Leif Bergsagel; V Roy; J R Mikhael; A Keith Stewart; K Laumann; J B Allred; Sumithra J Mandrekar; S Vincent Rajkumar; Francis Buadi
Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).
Leukemia 2010;24(11):1934-9.
2010: Arne Traulsen; Jorge M Pacheco; Lucio Luzzatto; David Dingli
Somatic mutations and the hierarchy of hematopoiesis.
BioEssays : news and reviews in molecular, cellular and developmental biology 2010;32(11):1003-8.
2010: Angela Dispenzieri; David Dingli; Shaji K Kumar; S Vincent Rajkumar; Martha Q Lacy; Suzanne R Hayman; Frances Buadi; Steven R Zeldenrust; Nelson Leung; Kristen Detweiler-Short; John A Lust; Stephen J Russell; Robert A Kyle; Morie A Gertz
Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs.
American journal of hematology 2010;85(10):757-9.
2010: Matthew K Ennis; Chunling Hu; Shruthi K Naik; Louay K Hallak; Kah-Whye Peng; stephen russell; David Dingli
Mutations in the stalk region of the measles virus hemagglutinin inhibit syncytium formation but not virus entry.
Journal of virology 2010;84(20):10913-7.
2010: David Dingli; Bonnie K Arendt; Zeljko Bajzer; Diane F Jelinek
Evolutionary dynamics of two related malignant plasma cell lines.
Cell cycle (Georgetown, Tex.) 2010;9(18):3792-7.
2010: Alan R Penheiter; Troy R Wegman; Kelly L Classic; David Dingli; Claire E Bender; Stephen J Russell; Stephanie K Carlson
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer.
AJR. American journal of roentgenology 2010;195(2):341-9.
2010: H Li; Kah-Whye Peng; David Dingli; R A Kratzke; stephen russell
Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy.
Cancer gene therapy 2010;17(8):550-8.
2010: Arne Traulsen; Jorge M Pacheco; David Dingli
Reproductive fitness advantage of BCR-ABL expressing leukemia cells.
Cancer letters 2010;294(1):43-8.
2010: Monica M Reinholz; Shawn P Zinnen; Amylou Dueck; David Dingli; Gregory G Reinholz; Leslie A Jonart; Kathleen A Kitzmann; Amy K Bruzek; Vivian Negron; Abdalla K Abdalla; Bonnie K Arendt; Anthony J Croatt; Luis Sanchez-Perez; David P Sebesta; Harri Lönnberg; Toshiyuki Yoneda; Karl A Nath; Diane F Jelinek; Stephen J Russell; James N Ingle; Thomas C Spelsberg; Henry B F Hal Dixon; Alexander Karpeisky; Wilma L Lingle
A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites.
Bone 2010;47(1):12-22.
2010: Angela Dispenzieri; Gregory A Wiseman; Martha Q Lacy; Suzanne R Hayman; Shaji K Kumar; Francis Buadi; David Dingli; Krista M Laumann; Jake Allred; Susan M Geyer; Mark R Litzow; Dennis A Gastineau; David J Inwards; Ivana N M Micallef; Stephen M Ansell; Luis F Porrata; Michelle A Elliott; Patrick B Johnston; William J Hogan; Morie A Gertz
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
American journal of hematology 2010;85(6):409-13.
2010: Tom Lenaerts; Jorge M Pacheco; Arne Traulsen; David Dingli
Tyrosine kinase inhibitor therapy can cure chronic myeloid leukemia without hitting leukemic stem cells.
Haematologica 2010;95(6):900-7.
2010: David Dingli; S Vincent Rajkumar
How best to use new therapies in multiple myeloma.
Blood reviews 2010;24(3):91-100.
2010: David Dingli; Tom Lenaerts; Arne Traulsen; Jorge M Pacheco
Evolutionary dynamics of chronic myeloid leukemia.
Genes & cancer 2010;1(4):309-15.
2010: Morie A Gertz; Shaji Kumar; Martha Q Lacy; Angela Dispenzieri; David Dingli; Suzanne R Hayman; Francis K Buadi; William J Hogan
Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide induction.
Blood 2010;115(12):2348-53; quiz 2560.
2010: David Dingli; T S Tan; S K Kumar; Francis Buadi; Angela Dispenzieri; Suzanne R Hayman; Martha Q Lacy; Dennis A Gastineau; William J Hogan; M A Gertz
Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis.
Neurology 2010;74(11):913-8.
2010: David Dingli; Jorge M Pacheco
Modeling the architecture and dynamics of hematopoiesis.
Wiley interdisciplinary reviews. Systems biology and medicine 2010;2(2):235-44.
2010: Matthew K Ennis; David Dingli
Death by fusion for acute leukemia cells.
Cancer biology & therapy 2010;9(5):358-61.
2010: Shirshendu Sinha; S Vincent Rajkumar; Martha Q Lacy; Suzanne R Hayman; Francis K Buadi; Angela Dispenzieri; David Dingli; Robert A Kyle; Morie A Gertz; Shaji Kumar
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma.
British journal of haematology 2010;148(6):853-8.
2010: Francesca Gay; Suzanne R Hayman; Martha Q Lacy; Francis Buadi; Morie A Gertz; Shaji Kumar; Angela Dispenzieri; Joseph R Mikhael; P Leif Bergsagel; David Dingli; Craig B Reeder; John A Lust; Stephen J Russell; Vivek Roy; Steven R Zeldenrust; Thomas E Witzig; Rafael Fonseca; Robert A Kyle; Philip R Greipp; A Keith Stewart; S Vincent Rajkumar
Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients.
Blood 2010;115(7):1343-50.
2010: Matt Biesecker; Jung-Han Kimn; Huitian Lu; David Dingli; Zeljko Bajzer
Optimization of virotherapy for cancer.
Bulletin of mathematical biology 2010;72(2):469-89.
2010: Aaron Mansfield; Brenda Larson; Scott L Stafford; Thomas C Shives; Michael G Haddock; David Dingli
Angiomatoid fibrous histiocytoma in a 25-year-old male.
Rare tumors 2010;2(2):e20.
2010: Carlos L Reis; Jorge M Pacheco; Matthew K Ennis; David Dingli
In silico evolutionary dynamics of tumour virotherapy.
Integrative biology : quantitative biosciences from nano to macro 2010;2(1):41-5.
2009: Shaji K Kumar; Joseph R Mikhael; Francis K Buadi; David Dingli; Angela Dispenzieri; Rafael Fonseca; Morie A Gertz; Philip R Greipp; Suzanne R Hayman; Robert A Kyle; Martha Q Lacy; John A Lust; Craig B Reeder; Vivek Roy; Stephen J Russell; Kristen E Detweiler Short; A Keith Stewart; Thomas E Witzig; Steven R Zeldenrust; Robert J Dalton; S Vincent Rajkumar; P Leif Bergsagel
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines.
Mayo Clinic proceedings. Mayo Clinic 2009;84(12):1095-110.
2009: Martha Q Lacy; Sumithra Mandrekar; Angela Dispenzieri; Suzanne R Hayman; Shaji Kumar; Francis Buadi; David Dingli; Mark R Litzow; Peter Wettstein; Douglas Padley; Brian Kabat; Dennis A Gastineau; S Vincent Rajkumar; Morie A Gertz
Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival.
American journal of hematology 2009;84(12):799-802.
2009: David Dingli; C Offord; Rae Myers; Kah-Whye Peng; T W Carr; K Josic; stephen russell; Zeljko Bajzer
Dynamics of multiple myeloma tumor therapy with a recombinant measles virus.
Cancer gene therapy 2009;16(12):873-82.
2009: Martha Q Lacy; Suzanne R Hayman; Morie A Gertz; Angela Dispenzieri; Francis Buadi; Shaji Kumar; Philip R Greipp; John A Lust; Stephen J Russell; David Dingli; Robert A Kyle; Rafael Fonseca; P Leif Bergsagel; Vivek Roy; Joseph R Mikhael; A Keith Stewart; Kristina Laumann; Jacob B Allred; Sumithra J Mandrekar; S Vincent Rajkumar
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):5008-14.
2009: Morie A Gertz; Nelson Leung; Martha Q Lacy; Angela Dispenzieri; Steven R Zeldenrust; Suzanne R Hayman; Francis K Buadi; David Dingli; Philip R Greipp; Shaji K Kumar; John A Lust; S Vincent Rajkumar; Stephen J Russell; Thomas E Witzig
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(10):3132-7.
2009: Jorge M Pacheco; Arne Traulsen; David Dingli
The allometry of chronic myeloid leukemia.
Journal of theoretical biology 2009;259(3):635-40.
2009: Prashant Kapoor; Shaji Kumar; Rafael Fonseca; Martha Q Lacy; Thomas E Witzig; Suzanne R Hayman; Angela Dispenzieri; Francis Buadi; P Leif Bergsagel; Morie A Gertz; Robert J Dalton; Joseph R Mikhael; David Dingli; Craig B Reeder; John A Lust; stephen russell; Vivek Roy; Steven R Zeldenrust; A Keith Stewart; Robert A Kyle; Philip R Greipp; S Vincent Rajkumar
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone.
Blood 2009;114(3):518-21.
2009: Luciano J Costa; Shaji Kumar; Angela Dispenzieri; Suzanne E Hayman; Francis K Buadi; David Dingli; Mark R Litzow; Morie A Gertz; Martha Q Lacy
Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
Leukemia & lymphoma 2009;50(5):781-7.
2009: David Dingli; S Vincent Rajkumar
Emerging therapies for multiple myeloma.
Oncology (Williston Park, N.Y.) 2009;23(5):407-15.
2009: Morie A Gertz; Shaji Kumar; Martha Q Lacy; Angela Dispenzieri; Suzanne R Hayman; Francis Buadi; David Dingli; Dennis A Gastineau; Jeffrey L Winters; Mark R Litzow
Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.
Bone marrow transplantation 2009;43(8):619-25.
2008: Jorge M Pacheco; Arne Traulsen; Tibor Antal; David Dingli
Cyclic neutropenia in mammals.
American journal of hematology 2008;83(12):920-1.
2008: David Dingli; Lucio Luzzatto; Jorge Pacheco
Neutral evolution in paroxysmal nocturnal hemoglobinuria.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(47):18496-500.
2008: David Dingli; Arne Traulsen; Jorge Pacheco
Dynamics of haemopoiesis across mammals.
Proceedings. Biological sciences / The Royal Society 2008;275(1649):2389-92.
2008: Morie A Gertz; Stephen M Ansell; David Dingli; Angela Dispenzieri; Francis K Buadi; Michelle A Elliott; Dennis A Gastineau; Suzanne R Hayman; William J Hogan; David J Inwards; Patrick B Johnston; Shaji Kumar; Martha Q Lacy; Nelson Leung; Ivana N M Micallef; Luis F Porrata; Barbara A Schafer; Robert C Wolf; Mark R Litzow
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative.
Mayo Clinic proceedings. Mayo Clinic 2008;83(10):1131-8.
2008: Shaji Kumar; S T Mahmood; Martha Q Lacy; Angela Dispenzieri; Suzanne R Hayman; Francis Buadi; David Dingli; S Vincent Rajkumar; Mark R Litzow; Morie A Gertz
Impact of early relapse after auto-SCT for multiple myeloma.
Bone marrow transplantation 2008;42(6):413-20.
2008: Sk Kumar; David Dingli; Angela Dispenzieri; Mq Lacy; Suzanne R Hayman; Fk Buadi; Sv Rajkumar; Mr Litzow; Ma Gertz
Impact of additional cytoreduction following autologous SCT in multiple myeloma.
Bone marrow transplantation 2008;42(4):259-64.
2008: Shaji K Kumar; David Dingli; Martha Q Lacy; Angela Dispenzieri; Suzanne R Hayman; Francis K Buadi; S Vincent Rajkumar; Mark R Litzow; Morie A Gertz
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.
American journal of hematology 2008;83(8):614-7.
2008: Shaji Kumar; David Dingli; Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Francis Buadi; S Vincent Rajkumar; Mark R Litzow; Morie A Gertz
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.
Bone marrow transplantation 2008;41(12):1013-9.
2008: Zeljko Bajzer; Thomas Carr; Kresimir Josić; stephen russell; David Dingli
Modeling of cancer virotherapy with recombinant measles viruses.
Journal of theoretical biology 2008;252(1):109-22.
2008: David Dingli; Val J. Lowe
Plasma membrane phospholipid labeling to estimate tumor burden and kinetics.
Cancer biology & therapy 2008;7(5):748-9.
2008: Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Shaji K Kumar; Francis Buadi; David Dingli; Mark R Litzow; Dennis A Gastineau; David J Inwards; Michelle A Elliott; Ivana N M Micallef; Stephen M Ansell; William J Hogan; Luis F Porrata; Patrick A Johnston; Bekele Afessa; Alan Bryce; Robert A Kyle; Morie A Gertz
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.
European journal of haematology 2008;80(5):397-406.
2008: Shaji K Kumar; David Dingli; Martha Q Lacy; Angela Dispenzieri; Suzanne R Hayman; Francis K Buadi; S Vincent Rajkumar; Mark R Litzow; Morie A Gertz
Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.
British journal of haematology 2008;141(2):205-11.
2008: Shaji Kumar; S Vincent Rajkumar; Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Francis K Buadi; Steven R Zeldenrust; David Dingli; stephen russell; John A Lust; Philip R Greipp; Robert A Kyle; Morie A Gertz
Improved survival in multiple myeloma and the impact of novel therapies.
Blood 2008;111(5):2516-20.
2008: David Dingli; Jorge Pacheco; Arne Traulsen
Multiple mutant clones in blood rarely coexist.
Physical review. E, Statistical, nonlinear, and soft matter physics 2008;77(2 Pt 1):021915.
2008: David Dingli; Jorge Pacheco
Some dynamic aspects of hematopoietic stem cells.
Stem cell reviews 2008;4(1):57-64.
2007: R M Myers; Suzanne Greiner; Mary E Harvey; guy griesmann; Mary J Kuffel; Sarah A Buhrow; Joel M Reid; Mark J Federspiel; Matthew M Ames; David Dingli; Karen M Schweikart; A Welch; Angela Dispenzieri; Kah-Whye Peng; stephen russell
Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide.
Clinical pharmacology and therapeutics 2007;82(6):700-10.
2007: Arne Traulsen; Jorge Pacheco; David Dingli
On the origin of multiple mutant clones in paroxysmal nocturnal hemoglobinuria.
Stem cells (Dayton, Ohio) 2007;25(12):3081-4.
2007: Joao V Lopes; Jorge Pacheco; David Dingli
Acquired hematopoietic stem-cell disorders and mammalian size.
Blood 2007;110(12):4120-2.
2007: Niko Beerenwinkel; Tibor Antal; David Dingli; Arne Traulsen; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Martin A Nowak
Genetic progression and the waiting time to cancer.
PLoS computational biology 2007;3(11):e225.
2007: David Dingli; Jorge Pacheco; Grzegorz S Nowakowski; Shaji Kumar; Angela Dispenzieri; Suzanne R Hayman; Martha Q Lacy; Dennis A Gastineau; Morie A Gertz
Relationship between depth of response and outcome in multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4933-7.
2007: Michelle A Elliott; S Verstovsek; David Dingli; S M Schwager; Ruben A Mesa; C Y Li; Ayalew Tefferi
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis.
Leukemia research 2007;31(11):1503-9.
2007: David Dingli; Jorge Pacheco
Ontogenic growth of the haemopoietic stem cell pool in humans.
Proceedings. Biological sciences / The Royal Society 2007;274(1624):2497-2501.
2007: David Dingli; stephen russell
Mouse models and the RANKL/OPG axis in myeloma bone disease.
Leukemia 2007;21(10):2090-3.
2007: Keith William Pratz; David Dingli; Thomas C Smyrk; John A Lust
Intestinal lymphangiectasia with protein-losing enteropathy in Waldenstrom macroglobulinemia.
Medicine 2007;86(4):210-4.
2007: Frank Kozusko; Michele Bourdeau; Zeljko Bajzer; David Dingli
A microenvironment based model of antimitotic therapy of Gompertzian tumor growth.
Bulletin of mathematical biology 2007;69(5):1691-708.
2007: David Dingli; Jorge Pacheco; Angela Dispenzieri; Suzanne R Hayman; Shaji Kumar; Martha Q Lacy; Dennis A Gastineau; Morie A Gertz
Serum M-spike and transplant outcome in patients with multiple myeloma.
Cancer science 2007;98(7):1035-40.
2007: David Dingli; Jorge Pacheco; Angela Dispenzieri; Suzanne R Hayman; Shaji Kumar; Martha Q Lacy; Dennis A Gastineau; Morie A Gertz
In vivo and in silico studies on single versus multiple transplants for multiple myeloma.
Cancer science 2007;98(5):734-9.
2007: David Dingli; Arne Traulsen; Franziska Michor; Fransizka Michor
(A)symmetric stem cell replication and cancer.
PLoS computational biology 2007;3(3):e53.
2007: David Dingli; Robert C Wolf; Adrian Vella
Imatinib and type 2 diabetes.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2007;13(2):126-30.
2007: David Dingli; Franziska Michor; Tibor Antal; Jorge Pacheco
The emergence of tumor metastases.
Cancer biology & therapy 2007;6(3):383-90.
2007: A K Stewart; P Leif Bergsagel; Philip R Greipp; Angela Dispenzieri; Morie A Gertz; Suzanne R Hayman; S Kumar; Martha Q Lacy; John A Lust; stephen russell; Thomas E Witzig; Steven R Zeldenrust; David Dingli; Craig B Reeder; V Roy; Robert A Kyle; S Vincent Rajkumar; Rafael Fonseca
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
Leukemia 2007;21(3):529-34.
2007: David Dingli; Arne Traulsen; Jorge Pacheco
Stochastic dynamics of hematopoietic tumor stem cells.
Cell cycle (Georgetown, Tex.) 2007;6(4):461-6.
2007: David Dingli; Arne Traulsen; Jorge Pacheco
Compartmental architecture and dynamics of hematopoiesis.
PloS one 2007;2(4):e345.
2006: David Dingli; Franziska Michor
Successful therapy must eradicate cancer stem cells.
Stem cells (Dayton, Ohio) 2006;24(12):2603-10.
2006: David Dingli; Robert A Kyle; S Vincent Rajkumar; Grzegorz S Nowakowski; Dirk R Larson; John P Bida; Morie A Gertz; Terry M Therneau; Joseph L Melton; Angela Dispenzieri; Jerry A Katzmann
Immunoglobulin free light chains and solitary plasmacytoma of bone.
Blood 2006;108(6):1979-83.
2006: David Dingli; Martin A Nowak
Cancer biology: infectious tumour cells.
Nature 2006;443(7107):35-6.
2006: Martha Q Lacy; Angela Dispenzieri; Morie A Gertz; Philip R Greipp; Kimberly L Gollbach; Suzanne R Hayman; Shaji Kumar; John A Lust; S Vincent Rajkumar; stephen russell; Thomas E Witzig; Steven R Zeldenrust; David Dingli; P Leif Bergsagel; Rafael Fonseca; Craig B Reeder; A Keith Stewart; Vivek Roy; Robert J Dalton; Alan B Carr; Deepak Kademani; Eugene E Keller; Christopher F Viozzi; Robert A Kyle
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2006;81(8):1047-53.
2006: David Dingli; Ayalew Tefferi
Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia.
Current hematologic malignancy reports 2006;1(2):69-74.
2006: Tait D Shanafelt; Y K Lee; Timothy G Call; Grzegorz S Nowakowski; David Dingli; Clive S Zent; Neil E Kay
Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies.
Leukemia research 2006;30(6):707-12.
2006: Ayalew Tefferi; David Dingli; Chin-Yang Li; Ruben A Mesa
Microcytosis in agnogenic myeloid metaplasia: prevalence and clinical correlates.
Leukemia research 2006;30(6):677-80.
2006: David Dingli; Susan M Schwager; Ruben A Mesa; Chin-Yang Li; Gordon W Dewald; Ayalew Tefferi
Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.
Cancer 2006;106(9):1985-9.
2006: David Dingli; Grzegorz S Nowakowski; Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; S Vincent Rajkumar; Philip R Greipp; Mark R Litzow; Dennis A Gastineau; Thomas E Witzig; Morie A Gertz
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system.
Blood 2006;107(8):3384-8.
2006: David Dingli; Grzegorz S Nowakowski; Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Mark R Litzow; Dennis A Gastineau; Morie A Gertz
Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myeloma.
Clinical lymphoma & myeloma 2006;6(5):384-8.
2006: David Dingli; Susan M Schwager; Ruben A Mesa; Chin-Yang Li; Ayalew Tefferi
Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system.
Cancer 2006;106(3):623-30.
2006: David Dingli; Jorge Pacheco
Allometric scaling of the active hematopoietic stem cell pool across mammals.
PloS one 2006;1():e2.
2006: David Dingli; Matthew D Cascino; Kresimir Josić; stephen russell; Zeljko Bajzer
Mathematical modeling of cancer radiovirotherapy.
Mathematical biosciences 2006;199(1):55-78.
2006: David Dingli; Brad J Kemp; Michael K O'Connor; John C Morris; stephen russell; Val J. Lowe
Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(1):16-23.
2005: David Dingli; S Vincent Rajkumar; Grzegorz S Nowakowski; Morie A Gertz; Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Rafael Fonseca; John A Lust; Robert A Kyle; Philip R Greipp; Thomas E Witzig
Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
Haematologica 2005;90(12):1650-4.
2005: David Dingli; Kah-Whye Peng; Mary E Harvey; Sompong Vongpunsawad; Elizabeth R Bergert; Robert A Kyle; Roberto Cattaneo; John C Morris; stephen russell
Interaction of measles virus vectors with Auger electron emitting radioisotopes.
Biochemical and biophysical research communications 2005;337(1):22-9.
2005: Ayalew Tefferi; David Dingli; Chin-Yang Li; Gordon W Dewald
Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.
Cancer 2005;104(8):1656-60.
2005: Ayalew Tefferi; Shireen Sirhan; Terra L Lasho; Susan M Schwager; Chin-Yang Li; David Dingli; alexandra wolanskyj; David P Steensma; Ruben A Mesa; D Gary Gilliland
Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia.
British journal of haematology 2005;131(2):166-71.
2005: Grzegorz S Nowakowski; Thomas E Witzig; David Dingli; Michal J Tracz; Morie A Gertz; Martha Q Lacy; John A Lust; Angela Dispenzieri; Philip R Greipp; Robert A Kyle; S Vincent Rajkumar
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma.
Blood 2005;106(7):2276-9.
2005: David Dingli; Dirk R Larson; Matthew F Plevak; Joseph P Grande; Robert A Kyle
Focal and segmental glomerulosclerosis and plasma cell proliferative disorders.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;46(2):278-82.
2005: David Dingli; Francis H Grand; Victor Mahaffey; Jack L Spurbeck; Fiona M Ross; Ann Watmore; John T Reilly; Nicholas C P Cross; Gordon W Dewald; Ayalew Tefferi
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia.
British journal of haematology 2005;130(2):229-32.
2005: David Dingli; Ayalew Tefferi
A critical review of anagrelide therapy in essential thrombocythemia and related disorders.
Leukemia & lymphoma 2005;46(5):641-50.
2004: David Dingli; Elizabeth R Bergert; Zeljko Bajzer; Michael K O'Connor; stephen russell; John C Morris
Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter.
Biochemical and biophysical research communications 2004;325(1):157-66.
2004: David Dingli; Ayalew Tefferi
Anagrelide: an update on its mechanisms of action and therapeutic potential.
Expert review of anticancer therapy 2004;4(4):533-41.
2004: David Dingli; Ruben A Mesa; Ayalew Tefferi
Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment.
Internal medicine (Tokyo, Japan) 2004;43(7):540-7.
2004: David Dingli; Kah-Whye Peng; Mary E Harvey; Philip R Greipp; Michael K O'Connor; Roberto Cattaneo; John C Morris; stephen russell
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter.
Blood 2004;103(5):1641-6.
2003: David Dingli; stephen russell; John C Morris
In vivo imaging and tumor therapy with the sodium iodide symporter.
Journal of cellular biochemistry 2003;90(6):1079-86.
2003: David Dingli; Rosa Maria Diaz; Elizabeth R Bergert; Michael K O'Connor; John C Morris; stephen russell
Genetically targeted radiotherapy for multiple myeloma.
Blood 2003;102(2):489-96.
2002: David Dingli; Michael M Timm; stephen russell; Thomas E Witzig; S Vincent Rajkumar
Promising preclinical activity of 2-methoxyestradiol in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3948-54.
2002: David Dingli; Dennis A Gastineau; GS Gilchrist; William L Nichols; JL Wilke
Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates.
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8(5):629-34.
2001: David Dingli; James P Utz; M A Gertz
Pulmonary hypertension in patients with amyloidosis.
Chest 2001;120(5):1735-8.
2001: David Dingli; James P Utz; Michael J Krowka; A L Oberg; Ayalew Tefferi
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
Chest 2001;120(3):801-8.
2000: David Dingli; D H Pfizenmaier; E Arromdee; P Wennberg; P C Spittell; A Chang-Miller; B L Clarke
Severe digital arterial occlusive disease and acute parvovirus B19 infection.
Lancet 2000;356(9226):312-4.
2000: David Dingli; T H Poterucha
65-year-old woman with swelling of the right lower limb.
Mayo Clinic proceedings. Mayo Clinic 2000;75(1):75-8.